|
|
|
Insider
Information: |
Emster Kurt Von |
Relationship: |
Director |
City: |
|
State: |
|
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
7 |
|
Direct
Shares |
302,614 |
|
Indirect Shares
|
18,297,697 |
|
|
Direct
Value |
$7,306,605 |
|
|
Indirect Value
|
$216,291,256 |
|
|
Total
Shares |
18,600,311 |
|
|
Total
Value |
$223,597,861 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Rigel Pharmaceuticals Inc |
RIGL |
10% Owner |
2003-06-26 |
173,611 |
2004-02-19 |
4,350,516 |
Premium* |
|
Somaxon Pharmaceuticals, Inc. |
SOMX |
Director |
2013-03-06 |
0 |
2013-03-06 |
0 |
Premium* |
|
Crispr Therapeutics Ag |
CRSP |
Director |
2018-06-05 |
90,000 |
2018-12-18 |
1,171,268 |
Premium* |
|
Cymabay Therapeutics, Inc. |
CBAY |
|
2024-03-22 |
0 |
2023-09-29 |
18,406 |
Premium* |
|
Vaxcyte, Inc. |
PCVX |
Director |
2020-06-16 |
0 |
2020-06-16 |
4,168,718 |
Premium* |
|
Vera Therapeutics, Inc. |
VERA |
Director |
2021-05-17 |
17,828 |
2021-05-18 |
2,960,231 |
Premium* |
|
Amplitude Healthcare Acquisition... |
AMHCU |
Director |
2023-04-13 |
21,175 |
2021-09-24 |
5,628,558 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
108 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 5
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
SOMX |
Somaxon Pharmaceuticals, ... |
officerTitle |
|
2005-12-20 |
4 |
A |
$0.00 |
$0 |
I/I |
291,807 |
291,807 |
|
- |
|
SOMX |
Somaxon Pharmaceuticals, ... |
Director |
|
2008-12-31 |
4 |
A |
$0.00 |
$0 |
D/D |
543 |
543 |
0 |
- |
|
SOMX |
Somaxon Pharmaceuticals, ... |
Director |
|
2009-03-31 |
4 |
A |
$0.00 |
$0 |
D/D |
28,571 |
29,251 |
0 |
- |
|
SOMX |
Somaxon Pharmaceuticals, ... |
Director |
|
2009-07-08 |
4 |
A |
$1.05 |
$44,681 |
I/I |
42,553 |
42,553 |
0 |
- |
|
SOMX |
Somaxon Pharmaceuticals, ... |
Director |
|
2009-09-30 |
4 |
A |
$0.00 |
$0 |
D/D |
3,886 |
43,137 |
0 |
- |
|
SOMX |
Somaxon Pharmaceuticals, ... |
Director |
|
2009-12-31 |
4 |
A |
$0.00 |
$0 |
D/D |
8,796 |
51,933 |
0 |
- |
|
SOMX |
Somaxon Pharmaceuticals, ... |
Director |
|
2010-03-31 |
4 |
A |
$0.00 |
$0 |
D/D |
1,283 |
53,216 |
0 |
- |
|
SOMX |
Somaxon Pharmaceuticals, ... |
Director |
|
2012-04-02 |
4 |
A |
$0.00 |
$0 |
D/D |
59,423 |
59,423 |
0 |
- |
|
SOMX |
Somaxon Pharmaceuticals, ... |
Director |
|
2012-07-02 |
4 |
A |
$0.00 |
$0 |
D/D |
61,579 |
121,002 |
0 |
- |
|
SOMX |
Somaxon Pharmaceuticals, ... |
Director |
|
2012-09-30 |
4 |
A |
$0.00 |
$0 |
D/D |
48,103 |
169,105 |
0 |
- |
|
SOMX |
Somaxon Pharmaceuticals, ... |
Director |
|
2012-12-31 |
4 |
A |
$0.00 |
$0 |
D/D |
6,541 |
27,679 |
0 |
- |
|
CRSP |
Crispr Therapeutics Ag |
Director |
|
2016-10-24 |
4 |
A |
$0.00 |
$0 |
I/I |
2,545,814 |
2,545,814 |
0 |
- |
|
PCVX |
Vaxcyte, Inc. |
Director |
|
2020-06-16 |
4 |
A |
$0.00 |
$0 |
I/I |
4,156,218 |
4,156,218 |
0 |
- |
|
VERA |
Vera Therapeutics, Inc. |
Director |
|
2021-05-18 |
4 |
A |
$0.00 |
$0 |
I/I |
2,187,504 |
2,187,504 |
0 |
- |
|
AMHCU |
Amplitude Healthcare Acqu... |
Director |
|
2022-10-12 |
4 |
A |
$0.00 |
$0 |
D/D |
30,250 |
30,250 |
0 |
- |
|
SOMX |
Somaxon Pharmaceuticals, ... |
Director |
|
2010-12-02 |
4 |
AS |
$2.78 |
$72,301 |
I/I |
(26,000) |
27,079 |
0 |
- |
|
CRSP |
Crispr Therapeutics Ag |
Director |
|
2017-06-22 |
4 |
AS |
$16.21 |
$24,753 |
I/I |
(1,527) |
2,600,287 |
0 |
- |
|
CRSP |
Crispr Therapeutics Ag |
Director |
|
2017-06-23 |
4 |
AS |
$16.23 |
$500,549 |
I/I |
(30,841) |
2,569,446 |
0 |
- |
|
CRSP |
Crispr Therapeutics Ag |
Director |
|
2017-06-26 |
4 |
AS |
$16.83 |
$807,857 |
I/I |
(48,001) |
2,521,445 |
0 |
- |
|
CRSP |
Crispr Therapeutics Ag |
Director |
|
2017-06-27 |
4 |
AS |
$17.43 |
$582,755 |
I/I |
(33,434) |
2,488,011 |
0 |
- |
|
CRSP |
Crispr Therapeutics Ag |
Director |
|
2017-06-28 |
4 |
AS |
$17.04 |
$538,328 |
I/I |
(31,592) |
2,456,419 |
0 |
- |
|
CRSP |
Crispr Therapeutics Ag |
Director |
|
2017-06-29 |
4 |
AS |
$16.52 |
$191,797 |
I/I |
(11,610) |
2,444,809 |
0 |
- |
|
CRSP |
Crispr Therapeutics Ag |
Director |
|
2017-07-05 |
4 |
AS |
$16.26 |
$69,170 |
I/I |
(4,254) |
2,440,555 |
0 |
- |
|
CRSP |
Crispr Therapeutics Ag |
Director |
|
2017-07-11 |
4 |
AS |
$16.52 |
$233,262 |
I/I |
(14,120) |
2,426,435 |
0 |
- |
|
CRSP |
Crispr Therapeutics Ag |
Director |
|
2017-07-12 |
4 |
AS |
$16.60 |
$296,675 |
I/I |
(17,872) |
2,408,563 |
0 |
- |
|
108 Records found
|
|
Page 1 of 5 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|